DUPIXENT
DUPIXENT
Approved
DIN Number
02470365
Drug Class
Human
Market Date
Feb 6, 2018
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02470365
AIG Number0159790001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
D11AH05 DUPILUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
DUPILUMABActive
Strength: 300 MG / 2 ML
Monograph: DUPILUMAB